Sort
16,300 grants matching “fatty liver disease”
Dietary And Lifestyle Determinants Of Colon Cancer Recurrence and Survival
$464,372Charles S Fuchs · Dana-Farber Cancer Inst · R01 · FY2016 · CA
Quantitative Oncologic PET-MR
$464,155Georges El Fakhri · Massachusetts General Hospital · R01 · FY2014 · CA
CLINICAL STUDIES OF NONALCOHOLIC STEATOHEPATITIS
$464,108Virginia Commonwealth University · U01 · FY2004 · DK
Novel Nanomedicine-Based Therapeutic Approach For Treatment of Cancer Cachexia
$464,065Oleh Taratula · Oregon State University · R37 · FY2020 · CA
Analysis of Lipolytic Trafficking in Adipocytes.
$463,992James G Granneman · Wayne State University · R01 · FY2021 · DK
Analysis of Lipolytic Trafficking in Adipocytes.
$463,992James G Granneman · Wayne State University · R01 · FY2025 · DK
Analysis of Lipolytic Trafficking in Adipocytes.
$463,992James G Granneman · Wayne State University · R01 · FY2023 · DK
Analysis of Lipolytic Trafficking in Adipocytes.
$463,992James G Granneman · Wayne State University · R01 · FY2022 · DK
3D bioprinting of liver tissue models
$463,965Marc Ferrer · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
Real time fine needle assessment of architectural heterogeneity in prostate cancer
$463,964Guan Xu · University Of Michigan At Ann Arbor · R37 · FY2025 · CA
Role of Hepatic Fatty Acid Oxidation in Metabolic Homeostasis
$463,955Michael J. Wolfgang · Johns Hopkins University · R01 · FY2019 · DK
Glycerol Regulation of Gluconeogenesis and Fatty Acid Metabolism
$463,943Fredric E. Wondisford · University Of Arizona · R01 · FY2025 · DK
Effects of Sleep Self-Restriction on Physical Activity and Diabetes Risk
$463,933Plamen Penev · University Of Chicago · R01 · FY2008 · HL
Lipid Droplets and Transcriptional Regulation of Metabolism
$463,922Tobias C Walther · Harvard School Of Public Health · R01 · FY2020 · DK
Natural History, Therapy and Pathogenesis of Chronic Viral Hepatitis C
$463,833Marc Ghany · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2019 · DK
Effect of Alcohol on Obesity Related Liver Disease
$463,796Arun J Sanyal · Virginia Commonwealth University · R01 · FY2013 · AA
Energy Expenditure and Metabolic Effects through Brown/Beige Adipose Clk2 Kinase
$463,725Pere Puigserver · Dana-Farber Cancer Inst · R01 · FY2020 · DK
Energy Expenditure and Metabolic Effects through Brown/Beige Adipose Clk2 Kinase
$463,725Pere Puigserver · Dana-Farber Cancer Inst · R01 · FY2017 · DK
Energy Expenditure and Metabolic Effects through Brown/Beige Adipose Clk2 Kinase
$463,725Pere Puigserver · Dana-Farber Cancer Inst · R01 · FY2019 · DK
Small Molecule PAR1 Ligands for the Treatment of MASH
$463,714Christopher Dockendorff · Function Therapeutics, Inc. · R43 · FY2024 · DK
Interactions between prenatal obesogen exposure and Total Western diet lead to a transgenerational thrifty phenotype: functional and epigenomic analysis of effects in fat and liver
$463,639Bruce Blumberg · University Of California-Irvine · R01 · FY2023 · ES
Phospholipid-Mediated Metabolic Control in the Pathogenesis of NAFLD
$463,494David E Cohen · Brigham And Women'S Hospital · R01 · FY2024 · DK
Determining the Role of apoC-III in the Immune System
$463,302Alison Bloom Kohan · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · DK
MR Imaging of Non-Alcoholic Fatty Liver Disease
$463,288Claude B Sirlin · University Of California, San Diego · R01 · FY2008 · DK
Cellular and molecular mechanisms of target tissue resistance for mitigating GVHD severity
$463,239Pavan Reddy · University Of Michigan At Ann Arbor · R01 · FY2019 · CA